share_log

Psychedelic Stock Gainers And Losers From January 17, 2023

Psychedelic Stock Gainers And Losers From January 17, 2023

自 2023 年 1 月 17 日起 Psychedelic 股票的涨跌幅
Benzinga Real-time News ·  2023/01/17 16:32

GAINERS:

赢家:

  • Numinus Wellness (OTC:NUMIF) shares closed up 30.82% at $0.22
  • Seelos Therapeutics (NASDAQ:SEEL) shares closed up 14.29% at $1.04
  • Mind Medicine (NASDAQ:MNMD) shares closed up 9.48% at $3.58
  • ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.78% at $1.94
  • Compass Pathways (NASDAQ:CMPS) shares closed up 1.47% at $9.69
  • 努米努斯健康 (场外交易代码:NUMIF)股价收盘上涨30.82%,至0.22美元
  • Seelos Therap 纳斯达克股票代码:SEEL)股价收盘上涨14.29%,至1.04美元
  • 心灵医学 纳斯达克股票代码:MNMD)股价收盘上涨9.48%,至3.58美元
  • ATAI 生命科学 纳斯达克股票代码:ATAI)股价收盘上涨7.78%,至1.94美元
  • 罗盘之路 纳斯达克股票代码:CMPS)股价收盘上涨1.47%,至9.69美元

LOSERS:

失败者:

  • Cybin (AMEX:CYBN) shares closed down 2.22% at $0.44
  • GH Research (NASDAQ:GHRS) shares closed down 0.57% at $9.65
  • Cybin (AMEX: CYBN)股价收盘下跌2.22%,至0.44美元
  • 生长激素研究 纳斯达克股票代码:GHRS)股价收盘下跌0.57%,至9.65美元

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发